Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 409

1.

Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.

Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ.

J Nucl Cardiol. 2005 May-Jun;12(3):294-301.

PMID:
15944534
2.

Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.

Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA.

J Nucl Med. 2009 Jun;50(6):959-65. doi: 10.2967/jnumed.108.060749.

3.
4.

The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging.

Bengel FM.

J Nucl Cardiol. 2005 May-Jun;12(3):255-7. No abstract available.

PMID:
15944528
5.

Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.

Fifer KM, Qadir S, Subramanian S, Vijayakumar J, Figueroa AL, Truong QA, Hoffmann U, Brady TJ, Tawakol A.

J Am Coll Cardiol. 2011 Feb 22;57(8):971-6. doi: 10.1016/j.jacc.2010.09.056. Erratum in: J Am Coll Cardiol. 2011 Apr 19;57(16):1717. Hoffman, Udo [corrected to Hoffmann, Udo].

6.

Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.

Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, Mounessa JS, Roytman M, Moon MJ, Lin J, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA.

JACC Cardiovasc Imaging. 2011 Oct;4(10):1100-9. doi: 10.1016/j.jcmg.2011.04.020.

7.

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.

Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ.

J Am Coll Cardiol. 2006 Nov 7;48(9):1818-24.

8.

(18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study.

Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, Kudomi N, Shiomi M, Magata Y, Iida H, Saji H.

J Nucl Med. 2004 Jul;45(7):1245-50.

9.

Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.

Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA.

Atherosclerosis. 2013 Jun;228(2):339-45. doi: 10.1016/j.atherosclerosis.2013.03.019.

10.

Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.

Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE, Ylä-Herttuala S, Saukko P, Nuutila P, Roivainen A, Knuuti J.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1294-301. doi: 10.1016/j.jcmg.2011.07.009.

11.

Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.

Ogawa M, Magata Y, Kato T, Hatano K, Ishino S, Mukai T, Shiomi M, Ito K, Saji H.

J Nucl Med. 2006 Nov;47(11):1845-50.

12.

Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.

Ben-Haim S, Kupzov E, Tamir A, Israel O.

J Nucl Med. 2004 Nov;45(11):1816-21.

13.

Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.

Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS.

Circulation. 2008 Apr 22;117(16):2061-70. doi: 10.1161/CIRCULATIONAHA.106.652313.

14.

FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.

Davies JR, Izquierdo-Garcia D, Rudd JH, Figg N, Richards HK, Bird JL, Aigbirhio FI, Davenport AP, Weissberg PL, Fryer TD, Warburton EA.

Int J Cardiovasc Imaging. 2010 Jan;26(1):41-8. doi: 10.1007/s10554-009-9506-6.

PMID:
19784796
15.

Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography.

Elmaleh DR, Fischman AJ, Tawakol A, Zhu A, Shoup TM, Hoffmann U, Brownell AL, Zamecnik PC.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15992-6.

16.

Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG).

Lederman RJ, Raylman RR, Fisher SJ, Kison PV, San H, Nabel EG, Wahl RL.

Nucl Med Commun. 2001 Jul;22(7):747-53.

PMID:
11453046
17.
18.

Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Jezovnik MK, Zidar N, Lezaic L, Gersak B, Poredos P.

Inflammation. 2014 Apr;37(2):426-34. doi: 10.1007/s10753-013-9755-3.

PMID:
24282108
19.

Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.

Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA.

Circ Cardiovasc Imaging. 2009 Mar;2(2):107-15. doi: 10.1161/CIRCIMAGING.108.811752.

20.

Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.

Hellberg S, Silvola JM, Kiugel M, Liljenbäck H, Metsälä O, Viljanen T, Metso J, Jauhiainen M, Saukko P, Nuutila P, Ylä-Herttuala S, Knuuti J, Roivainen A, Saraste A.

Cardiovasc Diabetol. 2016 Feb 6;15:26. doi: 10.1186/s12933-016-0340-6.

Supplemental Content

Support Center